A randomized phase III trial of platinum chemotherapy plus paclitaxel with bevacizumab and atezolizumab versus platinum chemotherapy plus paclitaxel and bevacizumab in metastatic (stage IVB), persistent, or recurrent carcinoma of the cervix: the BEATcc study (ENGOT-Cx10/GEICO 68-C/JGOG1084/GOG-3030)

Juan Francisco Grau; Lorena Farinas-Madrid; Ana Oaknin

doi:10.1136/ijgc-2019-000880

Citation Tools

other Versions

You are currently viewing an earlier version of this article (October 23, 2019).
View the most recent version of this article

Clinical trial

A randomized phase III trial of platinum chemotherapy plus paclitaxel with bevacizumab and atezolizumab versus platinum chemotherapy plus paclitaxel and bevacizumab in metastatic (stage IVB), persistent, or recurrent carcinoma of the cervix: the BEATcc study (ENGOT-Cx10/GEICO 68-C/JGOG1084/GOG-3030)

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:: Grau JF, Farinas-Madrid L, Oaknin A

A randomized phase III trial of platinum chemotherapy plus paclitaxel with bevacizumab and atezolizumab versus platinum chemotherapy plus paclitaxel and bevacizumab in metastatic (stage IVB), persistent, or recurrent carcinoma of the cervix: the BEATcc study (ENGOT-Cx10/GEICO 68-C/JGOG1084/GOG-3030)

International Journal of Gynecologic Cancer Published Online First: 23 October 2019. doi: 10.1136/ijgc-2019-000880

Log in using your username and password

Main menu

Log in using your username and password

You are here

other Versions

Download to a citation manager

Read the full text or download the PDF:

Log in using your username and password